CRISM Therapeutics Corp - Company Profile
Powered by 
All the sales intelligence you need on CRISM Therapeutics Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how CRISM Therapeutics Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with CRISM Therapeutics Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
CRISM Therapeutics Corp (CRISM Therapeutics) is a biotechnology company that specializes in the development of implantable drug delivery technologies for the treatment of solid tumors. The company utilizes ChemoSeed, an implantable biodegradable drug delivery technology to improve the clinical performance of cancer treatments for solid tumors through the delivery of chemotherapy drugs. CRISM Therapeutics also developing therapies for other solid tumors, including prostate cancer, pancreatic cancer, bladder cancer and breast cancer. The company offers services such as formulation services, and consultancy services. CRISM is headquartered in Tortola, British Virgin Islands, the UK.
Headquarters
United Kingdom
Address
Kingston Chambers, Road Town, Po Box 173, Tortola, British Virgin Islands, 680063
Website
www.crismtherapeutics.com/
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
CRTX (LON)
Revenue (2023)
$31,900
EPS
XYZ
Net Income (2023)
XYZ
91.7%
(2023 vs 2022)
Market Cap*
$10.0M
Net Profit Margin (2023)
XYZ
0.0%
(2023 vs 2022)
* As of and is in US$
Products and Services
| Products | Services | Brands |
|---|---|---|
| Technology Platform: | Formulation Services | ChemoSeed |
| ChemoSeed | Consultancy Services | |
| The LSLTE Platform | Drug Delivery | |
| XYZ | ||
| XYZ | ||
| XYZ |
Competitor Comparison
| Key Parameters | CRISM Therapeutics Corp | Oxford Biodynamics Plc | Kanabo Group, Plc | Nuformix Plc |
|---|---|---|---|---|
| Headquarters | United Kingdom | United Kingdom | United Kingdom | United Kingdom |
| City | Tortola | Oxford | London | London |
| State/Province | British Virgin Islands | England | England | England |
| No. of Employees | - | 41 | 17 | 3 |
| Entity Type | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Andrew James Webb | Chief Executive Officer; Chairman - Interim; Director | Executive Board | 2026 | 63 |
| Christopher McConville | Director; Chief Scientific Officer | Executive Board | - | - |
| Gerald Douglas Beaney | Director | Non Executive Board | 2025 | 65 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer